anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Show Traction

Slide function collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 11,828
Current window 4,861-4,890
Pages 395
Rows per page 30
Slide function: Show Tractionclear collectionreset all
18 30 60

Slide function

4,861-4,890 of 11,828

filter-aware
04
The chart uses a gradient arrow to emphasize the scale of 12.2M participants compared to other biobanks.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
07
The slide uses a timeline format to demonstrate regulatory milestones and credibility.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
08
The slide combines quantitative traction metrics with a qualitative customer story to validate the product's value proposition.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide highlights the scale of the 23andMe database and its application across three business pillars.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
16
Includes two mobile UI mockups showing personalized user results.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
20
The slide uses a gradient color scheme for the bars. The data is sourced from a 2019 survey of 1,046 customers.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
29
The slide uses a combination of a grid of metrics for general health conditions and a timeline for the COVID-19 study.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
31
The slide uses Manhattan plots to show genetic association density over time and a line chart to show the cumulative growth of independent hits.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
32
The slide uses a grid of small-multiple charts to show genetic association data across 12 medical categories. A specific example for NAFLD is highlighted at the bottom.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
40
The chart shows tumor growth inhibition over time, highlighting the triple combination (Anti-CD96 + Anti-TIGIT + Anti-PD1) as the most effective.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
59
The slide uses a 2-column layout to contrast established metrics with future/status indicators.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
06
Investor overview slide highlighting unit economics and customer loyalty.Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
13
Includes footnotes clarifying the data points.Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
14
The slide uses a map to visualize global footprint and lists specific countries with launch dates and population data.Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
19
The slide uses a three-column layout to frame the problem (low awareness) and the strategy (brand storytelling and product launches).Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
25
Includes CAGR and basis point improvement metrics.Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
08
AlTi | SPAC Presentation Deck | 33 slidesAlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank Beat · Financials1 hit
12
Includes a disclaimer note at the bottom regarding non-GAAP measures.AlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank 1 hit
13
The slide uses donut charts to illustrate asset composition by geography and client concentration.AlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank 1 hit
19
The slide uses a combination of bar charts for market context and a logo grid for proof points.AlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank 1 hit
06
Slide presents two distinct sections: financial performance (Net Sales/EBITDA) and company profile/market position.Azek | Investor Presentation Deck | 38 slides · The AZEK Company
Pitch deck Investor relations 1 hit
16
Azek | Investor Presentation Deck | 38 slidesAzek | Investor Presentation Deck | 38 slides · The AZEK Company
Pitch deck Investor relations 1 hit
19
The timeline is split into two tracks: internal product development (top) and acquisitions (bottom).Azek | Investor Presentation Deck | 38 slides · The AZEK Company
Pitch deck Investor relations 1 hit
31
Includes a 'Sales Growth Equation' diagram illustrating the drivers of long-term growth.Azek | Investor Presentation Deck | 38 slides · The AZEK Company
Pitch deck Investor relations Beat · Financials1 hit
32
The slide uses a combination of bar charts to show historical annual performance alongside quarterly comparisons.Azek | Investor Presentation Deck | 38 slides · The AZEK Company
Pitch deck Investor relations Beat · Financials1 hit
04
The slide uses a grid layout to present 8 distinct KPIs with supporting icons.Cazoo | Investor Presentation Deck | 13 slides · Cazoo
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
30
The slide uses a bar chart to demonstrate operating leverage through margin expansion.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
18
The data demonstrates target engagement via IP-10 induction, a biomarker for TREM2 activation.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
20
NHP = non-human primates. Data shows dose-dependent serum concentration and CSF target engagement.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
39
The data highlights the specificity of the drug candidate for brain tissue over peripheral circulation.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit